Zepbound (FDA-Approved for Weight Management) Zepbound\u00AE (tirzepatide) injection is an FDA-approved dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly and Company, indicated for chronic weight management in adults with obesity or overweight with at least one weight-related medical condition, used along with a reduced-calorie diet and increased physical activity
The 28% average body weight reduction observed in retatrutides Phase 3 programme, alongside an 82.4% reduction in liver fat in MASLD participants, positions it as the most potent incretin-based compound currently in late-stage development [2][4]
Long-term studies have shown sustained benefits and safety with appropriate medical monitoring, so be sure to use GLP-1 medication only under close supervision by your doctor
10.1001/archderm.141.12.1527
Love this company and products
Not the "I did not sleep well" kind of tired, but a deep, bone-level exhaustion that makes ordinary tasks feel monumental
&srotate=0)
